Acute myeloid leukemia stem cells can be made susceptible to chemotherapy by inducing them to divide.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Saito, Y. et al. Nat. Biotechnol. 28, 275–208 (2010).
Quintana, E. et al. Nature 456, 593–598 (2008).
Dick, J.E. Ann. NY Acad. Sci. 1044, 1–5 (2005).
Viale, A. et al. Nature 457, 51–56 (2009).
Ishikawa, F. et al. Nat. Biotechnol. 25, 1315–1321 (2007).
Löwenberg, B. et al. N. Engl. J. Med. 349, 743–752 (2003).
Estey, E.H. et al. Blood 93, 2478–2484 (1999).
Milligan, D.W., Wheatley, K., Littlewood, T., Craig, J.I. & Burnett, A.K. Blood 107, 4614–4622 (2006).
Essers, M.A. et al. Nature 458, 904–908 (2009).
Lane, S.W., Scadden, D.T. & Gilliland, D.G. Blood 114, 1150–1157 (2009).
Staub, M. & Eriksson, S. in Cancer Drug Discovery and Development: Deoxynucleoside Analogs in Cancer Therapy (ed. Peters, G.J.) 29–52 (Humana Press Inc., 2006).
Toy, G. et al. Proc. Natl. Acad. Sci. USA, published online, doi:10.1073/pnas.0913900107 (31 December 2009).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
C.G.R. is co-inventor on patent filings for novel PET probes for immunity and cancer based on DNA salvage pathways and co-founder and consultant to Sofie Biosciences, which is licensing this technology.
Rights and permissions
About this article
Cite this article
Mikkola, H., Radu, C. & Witte, O. Targeting leukemia stem cells. Nat Biotechnol 28, 237–238 (2010). https://doi.org/10.1038/nbt0310-237
Issue Date:
DOI: https://doi.org/10.1038/nbt0310-237
This article is cited by
-
Progress in RNAi-mediated Molecular Therapy of Acute and Chronic Myeloid Leukemia
Molecular Therapy - Nucleic Acids (2015)